- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
August 2nd, 2009
Iranians have developed a new method using nanotechnology to detect breast cancer in its early stages with the aim of lowering its mortality rate.
"Like many other countries, Iranians have been trying to achieve new therapeutic and diagnostic methods to treat cancer patients," said the head of Avicenna Research Center, Mohammad-Mehdi Akhoundi.
He added that Avicenna institute researchers have succeeded in developing a new method to diagnose breast cancer using the safe and non-toxic nanotechnology.
In this method, monoclonal antibody Her-2, the anti-tumoral marker of breast cancer, is produced. Marked with nano-particles, these antibodies are then injected in the body in order to detect the affected tumoral tissues.
Akhoundi concluded that after undergoing animal trials, the new technique can be used to detect breast cancer in its early stages, providing sufferers with more effective therapeutic interventions.
Avicenna researchers have also developed new techniques to treat various cancers such as blood malignancies, many of which will enter the market as soon as their animal testing is complete.
|Related News Press|
News and information
Stretching the limits on conducting wires July 25th, 2015
Nanopaper as an optical sensing platform July 23rd, 2015